
DocGo (DCGO) Stock Forecast & Price Target
DocGo (DCGO) Analyst Ratings
Bulls say
DocGo is positioned well in the growing market of last-mile mobile health services and integrated medical mobility solutions. Its proprietary logistics platform and lower-cost staffing model give it a competitive advantage in accessing this market opportunity. Despite a dip in revenue and adj-EBITDA expected in 2026 as a result of transitioning years, the company is expected to experience mid-teens-plus secular growth after 2026. Furthermore, recent developments such as expanded partnerships and increased patient volumes demonstrate the potential for future growth and differentiation in the industry.
Bears say
DocGo is heavily reliant on its Mobile Health Services segment, which faces challenges in scaling its revenue and right-sizing its costs. While the company's acquisition of SteadyMD and expansion into the value-based care market show potential, there is concern about the slow growth of its core business. The uncertainty surrounding the dissipation of COVID-related revenue and the company's ability to meet its forecasts also adds to the negative outlook. Overall, there is a need for DocGo to prove its ability to sustain and grow its business to justify its current valuation.
This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.
DocGo (DCGO) Analyst Forecast & Price Prediction
Start investing in DocGo (DCGO)
Order type
Buy in
Order amount
Est. shares
0 shares